The peptide influences both endothelial nitric oxide synthase (eNOS), which produces the beneficial, vasodilating form of nitric oxide, and inducible nitric oxide synthase (iNOS), which can produce excessive amounts that contribute to inflammation and tissue damage
Or, if you're looking for something we don't have yet, you can suggest something
Evidence behind the GLP-1 class Any credible GLP-1 program rests on the pharmacology of its underlying compounds GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide
Were not providing individual or group medical or healthcare advice, or establishing a provider-patient relationship
The combination of GLP-1R-mediated appetite suppression, GIPR-mediated adipose tissue metabolism, and GCGR-driven energy expenditure makes it one of the most comprehensive research tools for studying multi-pathway obesity biology in a single compound